OcuDyne Announces Positive Results for the OPTiC System™ 6-Month Clinical Trial in the Treatment of Geographic Atrophy
Ocudyne, Inc.A medical device company utilizing a novel approach to treat ocular disease, announced today the successful completion of a pilot study using its proprietary OPTiC System for treating Age-Related Macular Degeneration (AMD).